Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 07, 2025 03:30 ET | Source: Salipro Biotech AB

Salipro Biotech Strengthens Global IP Portfolio with Two New Japanese Patents

Salipro Biotech secures two new Japanese patents, strengthening its platform for stabilizing challenging membrane proteins to unlock new drug targets.
May 28, 2024 04:00 ET | Source: AKAMPION

selectION Announces Initiation of Phase 1b Clinical Trial Evaluating si-544 in Patients with Psoriasis Vulgaris or Psoriatic Arthritis

- New study follows completion of first-in-human Phase 1b trial in atopic dermatitis patients, in which selectION observed safety and tolerability of si-544 in the treatment of T cell autoimmunity ...
June 13, 2023 07:00 ET | Source: Salipro Biotech AB

Salipro Biotech Expands Global Intellectual Property Portfolio with Granted Patent in Japan

Salipro Biotech obtains granted patent in Japan, protecting its proprietary Salipro® platform technology to enable the development of therapeutics against challenging drug targets, including GPCRs,...
May 30, 2023 04:00 ET | Source: AKAMPION

selectION, Inc., Reports Interim Safety and Tolerability Results of Phase 1b Clinical Trial in Atopic Dermatitis

Ongoing phase 1b trial is designed to evaluate safety, tolerability, and efficacy of si-544 in T-cell mediated autoimmunity Dosing of MAD stage has been initiated; first results expected for late...
April 25, 2022 08:00 ET | Source: Vaccinex, Inc.

Vaccinex, Inc. Announces Upcoming Presentation at the PEGS Boston Conference & Expo Highlighting Its ActivMAb® Technology for Complex Membrane Antigen Expression to Enable Drug Discovery

ROCHESTER, N.Y., April 25, 2022 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and...